Home > Publications Database > Effect of the COVID-19 lockdown on disease recognition and utilisation of healthcare services in the older population in Germany: a cross-sectional study. > print

001     156006
005     20240305142007.0
024 7 _ |a 10.1093/ageing/afaa260
|2 doi
024 7 _ |a pmid:33205150
|2 pmid
024 7 _ |a pmc:PMC7717143
|2 pmc
024 7 _ |a 0002-0729
|2 ISSN
024 7 _ |a 1468-2834
|2 ISSN
024 7 _ |a altmetric:100219196
|2 altmetric
037 _ _ |a DZNE-2021-01138
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Michalowsky, Bernhard
|0 P:(DE-2719)2810763
|b 0
|u dzne
245 _ _ |a Effect of the COVID-19 lockdown on disease recognition and utilisation of healthcare services in the older population in Germany: a cross-sectional study.
260 _ _ |a Oxford
|c 2021
|b Oxford Univ. Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1709644756_29110
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a There is little evidence about the utilisation of healthcare services and disease recognition in the older population, which was urged to self-isolate during the COVID-19 lockdown.We aimed to describe the utilisation of physician consultations, specialist referrals, hospital admissions and the recognition of incident diseases in Germany for this age group during the COVID-19 lockdown.Cross-sectional observational study.1,095 general practitioners (GPs) and 960 specialist practices in Germany.2.45 million older patients aged 65 or older.The number of documented physician consultations, specialist referrals, hospital admissions and incident diagnoses during the imposed lockdown in 2020 was descriptively analysed and compared to 2019.Physician consultations decrease slightly in February (-2%), increase before the imposed lockdown in March (+9%) and decline in April (-18%) and May (-14%) 2020 compared to the same periods in 2019. Volumes of hospital admissions decrease earlier and more intensely than physician consultations (-39 versus -6%, respectively). Overall, 15, 16 and 18% fewer incident diagnoses were documented by GPs, neurologists and diabetologists, respectively, in 2020. Diabetes, dementia, depression, cancer and stroke were diagnosed less frequently during the lockdown (-17 to -26%), meaning that the decrease in the recognition of diseases was greater than the decrease in physician consultations.The data suggest that organisational changes were adopted quickly by practice management but also raise concerns about the maintenance of routine care. Prospective studies should evaluate the long-term effects of lockdowns on patient-related outcomes.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a COVID-19
|2 Other
650 _ 7 |a healthcare utilisation
|2 Other
650 _ 7 |a lockdown
|2 Other
650 _ 7 |a older people
|2 Other
650 _ 7 |a recognition
|2 Other
650 _ 2 |a Aged
|2 MeSH
650 _ 2 |a COVID-19: diagnosis
|2 MeSH
650 _ 2 |a COVID-19: epidemiology
|2 MeSH
650 _ 2 |a COVID-19: prevention & control
|2 MeSH
650 _ 2 |a COVID-19: therapy
|2 MeSH
650 _ 2 |a Communicable Disease Control: organization & administration
|2 MeSH
650 _ 2 |a Cross-Sectional Studies
|2 MeSH
650 _ 2 |a Delayed Diagnosis: adverse effects
|2 MeSH
650 _ 2 |a Delayed Diagnosis: statistics & numerical data
|2 MeSH
650 _ 2 |a Delivery of Health Care: methods
|2 MeSH
650 _ 2 |a Delivery of Health Care: organization & administration
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Germany: epidemiology
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Noncommunicable Diseases: epidemiology
|2 MeSH
650 _ 2 |a Noncommunicable Diseases: therapy
|2 MeSH
650 _ 2 |a Organizational Innovation
|2 MeSH
650 _ 2 |a Patient Acceptance of Health Care: statistics & numerical data
|2 MeSH
650 _ 2 |a Quarantine: methods
|2 MeSH
650 _ 2 |a SARS-CoV-2
|2 MeSH
700 1 _ |a Hoffmann, Wolfgang
|0 P:(DE-2719)2000040
|b 1
|u dzne
700 1 _ |a Bohlken, Jens
|b 2
700 1 _ |a Kostev, Karel
|b 3
773 _ _ |a 10.1093/ageing/afaa260
|g Vol. 50, no. 2, p. 317 - 325
|0 PERI:(DE-600)2065766-3
|n 2
|p 317 - 325
|t Age & ageing
|v 50
|y 2021
|x 1468-2834
909 C O |p VDB
|o oai:pub.dzne.de:156006
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)2810763
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 1
|6 P:(DE-2719)2000040
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2021
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-01-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2021-01-30
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-01-30
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2022-11-08
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b AGE AGEING : 2021
|d 2022-11-08
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-08
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-08
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2022-11-08
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2022-11-08
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-08
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-08
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-08
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2022-11-08
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b AGE AGEING : 2021
|d 2022-11-08
920 1 _ |0 I:(DE-2719)1510600
|k AG Hoffmann
|l Translational Health Care Research
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1510600
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21